This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) | MicrobiomeTrials
← Back to trials NCT07519395
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-04-08Est. Completion: 2027-03-09
Enrollment target: 420 participantsLocations GSK Investigational Site, Anniston, Alabama, United States GSK Investigational Site, Guntersville, Alabama, United States GSK Investigational Site, Mobile, Alabama, United States GSK Investigational Site, Saraland, Alabama, United States GSK Investigational Site, Scottsdale, Arizona, United States GSK Investigational Site, Tempe, Arizona, United States GSK Investigational Site, Anaheim, California, United States GSK Investigational Site, Chula Vista, California, United States GSK Investigational Site, Coronado, California, United States GSK Investigational Site, Garden Grove, California, United States GSK Investigational Site, Lancaster, California, United States GSK Investigational Site, Lancaster, California, United States GSK Investigational Site, Los Angeles, California, United States GSK Investigational Site, Murrieta, California, United States GSK Investigational Site, Pasadena, California, United States GSK Investigational Site, San Diego, California, United States Other microbiome trials you might be interested in IBS (Irritable Bowel Syndrome)
Study evaluating the effect of UCB8600 on mast cell activation in the human gut:
IBS is a disease characterized by abdo…
Leuven, Belgium Est. completion Oct 2027
Disorders of Gut-brain Interaction Lifestyle and Dietary Interventions Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder, with around 80% of patients experiencing n…
Hualien City, Taiwan Est. completion Dec 31, 2026
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, Sherman Oaks, California, United States
GSK Investigational Site, West Hills, California, United States
GSK Investigational Site, Aurora, Colorado, United States
GSK Investigational Site, Colorado Springs, Colorado, United States
GSK Investigational Site, Lone Tree, Colorado, United States
GSK Investigational Site, Brandon, Florida, United States
GSK Investigational Site, Clearwater, Florida, United States
GSK Investigational Site, Coral Gables, Florida, United States
GSK Investigational Site, Doral, Florida, United States
GSK Investigational Site, Hialeah, Florida, United States
GSK Investigational Site, Homestead, Florida, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Kissimmee, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami Beach, Florida, United States
GSK Investigational Site, Miami Lakes, Florida, United States
GSK Investigational Site, Miami Springs, Florida, United States
GSK Investigational Site, New Port Richey, Florida, United States
GSK Investigational Site, Ocala, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Palm Harbor, Florida, United States
GSK Investigational Site, Pembroke Pines, Florida, United States
GSK Investigational Site, Pembroke Pines, Florida, United States
GSK Investigational Site, Sunrise, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Decatur, Georgia, United States
GSK Investigational Site, Lawrenceville, Georgia, United States
GSK Investigational Site, Union City, Georgia, United States
GSK Investigational Site, Meridian, Idaho, United States
GSK Investigational Site, Morton, Illinois, United States
GSK Investigational Site, Oak Lawn, Illinois, United States
GSK Investigational Site, Ames, Iowa, United States
GSK Investigational Site, Houma, Louisiana, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Flint, Michigan, United States
GSK Investigational Site, Chesterfield, Missouri, United States
GSK Investigational Site, Hazelwood, Missouri, United States
GSK Investigational Site, Missoula, Montana, United States
GSK Investigational Site, Hartsdale, New York, United States
GSK Investigational Site, New Windsor, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, North Massapequa, New York, United States
GSK Investigational Site, Richmond Hill, New York, United States
GSK Investigational Site, Rochester, New York, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Fayetteville, North Carolina, United States
GSK Investigational Site, Greenville, North Carolina, United States
GSK Investigational Site, Rocky Mount, North Carolina, United States
GSK Investigational Site, Salisbury, North Carolina, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Beavercreek, Ohio, United States
GSK Investigational Site, Columbus, Ohio, United States
GSK Investigational Site, Mentor, Ohio, United States
GSK Investigational Site, Norman, Oklahoma, United States
GSK Investigational Site, Tulsa, Oklahoma, United States
GSK Investigational Site, Harrisburg, Pennsylvania, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Uniontown, Pennsylvania, United States
GSK Investigational Site, Chattanooga, Tennessee, United States
GSK Investigational Site, Chattanooga, Tennessee, United States
GSK Investigational Site, Johnson City, Tennessee, United States
GSK Investigational Site, Kingsport, Tennessee, United States
GSK Investigational Site, Knoxville, Tennessee, United States
GSK Investigational Site, Nashville, Tennessee, United States
GSK Investigational Site, Corsicana, Texas, United States
GSK Investigational Site, Georgetown, Texas, United States
GSK Investigational Site, Harlingen, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Mesquite, Texas, United States
GSK Investigational Site, Missouri City, Texas, United States
GSK Investigational Site, Pearland, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, Ogden, Utah, United States
GSK Investigational Site, Ogden, Utah, United States
GSK Investigational Site, Sandy City, Utah, United States
GSK Investigational Site, Lynchburg, Virginia, United States
GSK Investigational Site, Petersburg, Virginia, United States
GSK Investigational Site, Richmond, Virginia, United States Recruiting
Some people living with long-term physical health conditions report feeling dismissed, disbelieved, or not taken serious…
London, United Kingdom Est. completion Mar 1, 2027